Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia
NCT00434291 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 264
Last updated 2009-11-25
Summary
This study will test the safety and efficacy of TG-873870(Nemonoxacin) compared with Levofloxacin in adult patients with Community-Aquired Pneumonia(CAP)
Conditions
- Community-Acquired Pneumonia
Interventions
- DRUG
-
TG-873870(Nemonoxacin)
Sponsors & Collaborators
-
Quintiles, Inc.
collaborator INDUSTRY -
TaiGen Biotechnology Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Reury-Perng Perng, Doctor · Taipei Veterans General Hospital, Taipei, Taiwan
-
Ming-Lin Ho, Doctor · Chang-Hua Christian Hospital, Changhua, Taiwan
-
Wann-Cherng Perng, Doctor · Tri-Service General Hospital, Taipei, Taiwan
-
Kai-Ming Chang, Doctor · Taichung Veterans General Hospital, Taichung, Taiwan
-
Yen-Hsu Chen, Doctor · Kaoshiung Medical University Hospital, Kaoshiung, Taiwan
-
Ren-Guang Wu, Doctor · Cheng Ching Hospital, Taichung, Taiwan
-
Yin-Ching Chuang, Doctor · Chi-Mei Foundation Hospital, Tainan, Taiwan
-
Horng-Chyuan Lin, Doctor · Chang-Gung Memorial Hospital, Taoyuan, Taiwan
-
Yao-Kuang Wu, Doctor · Buddhist Taipei Tzu Chi General Hospital, Taipei, Taiwan
-
Hsi-Hsun Lin, Doctor · E-Da Hospital, Kaohsiung, Taiwan
-
AJ Bester, Doctor · GCT at Jubilee Hospital, RSA
-
J Breedt, Doctor · Bougainville Hospital, RSA
-
CT de Villiers, Doctor · de Villers Clinical Trials, RSA
-
M Gani, Doctor · GCT Trial Centre, Mercantile Hospital, RSA
-
Y Kelfkens, Doctor · Private, RSA
-
DJ Jansen van Rensburg, Doctor · Park Medical Centre, RSA
-
J Jurgens, Doctor · DJW Research, RSA
-
IH Mitha, Doctor · Benmed/Pentagon Hospital, RSA
-
JH Mynhardt, Doctor · Private, RSA
-
G Nieuwoudt, Doctor · MediTrials, RSA
-
J Kasumba, Doctor · JOSHA Research, RSA
-
E van Nieuwenhuizen, Doctor · Eastmed Clinical Trial Center, RSA
-
CJJ van Rensburg, Doctor · Private, RSA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Completion
- 2007-08-31
Countries
- South Africa
- Taiwan
Study Locations
More Related Trials
-
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
NCT00887276 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects
NCT00575094 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
NCT01524302 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia
NCT00257049 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
NCT00270517 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization
NCT00236834 ·Status: COMPLETED ·Phase: PHASE3
-
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
NCT07164131 ·Status: RECRUITING ·Phase: PHASE4
-
Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
NCT00429975 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
NCT00080496 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia
NCT00253955 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Nemonoxacin in Treating Elderly Patients With CAP
NCT05133752 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
NCT04409262 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
NCT00707239 ·Status: TERMINATED ·Phase: PHASE2
-
TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
NCT00789997 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT01886053 ·Status: COMPLETED ·Phase: PHASE2
-
The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens
NCT07035535 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults
NCT05313750 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis
NCT05344638 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
NCT01940731 ·Status: UNKNOWN ·Phase: PHASE2
-
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
NCT06916481 ·Status: RECRUITING
-
Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD
NCT01710488 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT01937832 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
NCT00653172 ·Status: COMPLETED ·Phase: PHASE2
-
Polycolistin E Sodium Mesylate Combined With Intravenous Atomization for Carbapenem Resistant Gram-negative Bacteria in Pulmonary Infection
NCT06907069 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Standardized Clinical Application of Antibacterial/Anitifungal Drugs
NCT04966390 ·Status: UNKNOWN